Gene · 3326
Papers4,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,343
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma. | Oxid Med Cell Longev | 2022 | 36211823 | PubTator, text mining | PubMed |
| Exploring the Molecular Mechanism of Tong Xie Yao Fang in Treating Ulcerative Colitis Using Network Pharmacology and Molecular Docking. | Evid Based Complement Alternat Med | 2022 | 36204124 | PubTator, text mining | PubMed |
| Tear proteome profile in eyes with keratoconus after intracorneal ring segment implantation or corneal crosslinking. | Front Med (Lausanne) | 2022 | 36203781 | PubTator, text mining | PubMed |
| E3 Ubiquitin Ligase CHIP Inhibits the Interaction between Hsp90β and MAST1 to Repress Radiation Resistance in Non-Small-Cell Lung Cancer Stem Cells. | Stem Cells Int | 2022 | 36199626 | PubTator, text mining | PubMed |
| Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop. | Mol Cancer | 2022 | 36199071 | PubTator, text mining | PubMed |
| Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease. | Chem Res Toxicol | 2022 | 36197742 | PubTator, text mining | PubMed |
| Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of Actinidia chinensis Planch. Root Extract for Application in Hepatocellular Carcinoma. | Evid Based Complement Alternat Med | 2022 | 36193154 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk. | Mol Ther Methods Clin Dev | 2022 | 36187720 | PubTator, text mining | PubMed |
| Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics. | Front Endocrinol (Lausanne) | 2022 | 36187110 | PubTator, text mining | PubMed |
| Chaperonin containing TCP-1 (CCT/TRiC) is a novel therapeutic and diagnostic target for neuroblastoma. | Front Oncol | 2022 | 36185250 | PubTator, text mining | PubMed |
| Comprehensive characterization of ubiquitinome of human colorectal cancer and identification of potential survival-related ubiquitination. | J Transl Med | 2022 | 36184622 | PubTator, text mining | PubMed |
| Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection. | EBioMedicine | 2022 | 36182629 | PubTator, text mining | PubMed |
| MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | Genome Biol | 2022 | 36180891 | PubTator, text mining | PubMed |
| Hyperelastic, shape-memorable, and ultra-cell-adhesive degradable polycaprolactone-polyurethane copolymer for tissue regeneration. | Bioeng Transl Med | 2022 | 36176615 | PubTator, text mining | PubMed |
| Utilizing network pharmacology and experimental validation to investigate the underlying mechanism of phellodendrine on inflammation. | PeerJ | 2022 | 36172495 | PubTator, text mining | PubMed |
| Lotus germ extract rejuvenates aging fibroblasts via restoration of disrupted proteostasis by the induction of autophagy. | Aging (Albany NY) | 2022 | 36170016 | PubTator, text mining | PubMed |
| Combined synchronization and superovulation treatments negatively impact embryo viability possibly by the downregulation of WNT/β-catenin and Notch signaling genes in the porcine endometrium. | J Anim Sci | 2022 | 36169657 | PubTator, text mining | PubMed |
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer. | World J Gastroenterol | 2022 | 36157542 | PubTator, text mining | PubMed |
| Chaperone-assisted E3 ligase CHIP: A double agent in cancer. | Genes Dis | 2022 | 36157498 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3326/papers?page=43